---
figid: PMC5297839__ijms-18-00210-g001
figtitle: Phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR),
  retrovirus-associated DNA sequences/mitogen activated protein kinase (RAS/MAPK)
  pathways and c-MYC are master regulators of cell growth and proliferation
organisms:
- NA
pmcid: PMC5297839
filename: ijms-18-00210-g001.jpg
figlink: /pmc/articles/PMC5297839/figure/ijms-18-00210-f001/
number: F1
caption: 'The phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR),
  retrovirus-associated DNA sequences/mitogen activated protein kinase (RAS/MAPK)
  pathways and c-MYC are master regulators of cell growth and proliferation. The PI3K/mTOR
  and RAS/MAPK signalling, and c-MYC transcription pathways are three major oncogenic
  drivers of cell growth and proliferation. They form a “super” network to regulate
  ribosome biogenesis and protein translation. The signalling cascades are predominantly
  initiated upon growth factor stimulation through receptor tyrosine kinases. Growth
  factors are represented by the green square and yellow circle. Activation of PI3K
  leads to induction of downstream effects mediated by the AKT oncoprotein including
  the activation of mTORC1 and subsequent phosphorylation of its downstream effectors,
  4E-BP1 and p70S6K1. Concomitantly, the RAS signalling pathway and the c-MYC transcription
  factor contribute to the control of ribosome biogenesis via modulating the synthesis
  of rRNAs by Pol I. Moreover, c-MYC also exerts its positive regulatory effects on
  Pol II, Pol III, and eIF4E. Together, these three key pathways promote ribosome
  synthesis and protein synthesis and thus cell growth. (PI3K: phosphatidylinositol-3-kinase;
  mTORC: mammalian target of rapamycin complex; PTEN: phosphatase and tensin homolog;
  PIP2: phosphatidylinositol-4,5-bisphosphate; PIP3: phosphatidylinositol-3,4,5-triphosphate;
  p70S6K1: p70 S6 kinase 1; 4E-BP1: eukaryotic initiation factor 4E-binding protein
  1; eIF4E: eukaryotic translation initiation factor 4E; rRNA: ribosomal RNA; Pol
  I: RNA Polymerase I; Pol II: RNA Polymerase II; Pol III: RNA Polymerase III). The
  grey arrows denote ongoing transcription.'
papertitle: The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian
  Cancer.
reftext: Shunfei Yan, et al. Int J Mol Sci. 2017 Jan;18(1):210.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9702074
figid_alias: PMC5297839__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5297839__F1
ndex: 8ccb2417-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5297839__ijms-18-00210-g001.html
  '@type': Dataset
  description: 'The phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR),
    retrovirus-associated DNA sequences/mitogen activated protein kinase (RAS/MAPK)
    pathways and c-MYC are master regulators of cell growth and proliferation. The
    PI3K/mTOR and RAS/MAPK signalling, and c-MYC transcription pathways are three
    major oncogenic drivers of cell growth and proliferation. They form a “super”
    network to regulate ribosome biogenesis and protein translation. The signalling
    cascades are predominantly initiated upon growth factor stimulation through receptor
    tyrosine kinases. Growth factors are represented by the green square and yellow
    circle. Activation of PI3K leads to induction of downstream effects mediated by
    the AKT oncoprotein including the activation of mTORC1 and subsequent phosphorylation
    of its downstream effectors, 4E-BP1 and p70S6K1. Concomitantly, the RAS signalling
    pathway and the c-MYC transcription factor contribute to the control of ribosome
    biogenesis via modulating the synthesis of rRNAs by Pol I. Moreover, c-MYC also
    exerts its positive regulatory effects on Pol II, Pol III, and eIF4E. Together,
    these three key pathways promote ribosome synthesis and protein synthesis and
    thus cell growth. (PI3K: phosphatidylinositol-3-kinase; mTORC: mammalian target
    of rapamycin complex; PTEN: phosphatase and tensin homolog; PIP2: phosphatidylinositol-4,5-bisphosphate;
    PIP3: phosphatidylinositol-3,4,5-triphosphate; p70S6K1: p70 S6 kinase 1; 4E-BP1:
    eukaryotic initiation factor 4E-binding protein 1; eIF4E: eukaryotic translation
    initiation factor 4E; rRNA: ribosomal RNA; Pol I: RNA Polymerase I; Pol II: RNA
    Polymerase II; Pol III: RNA Polymerase III). The grey arrows denote ongoing transcription.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - Raf
  - Pten
  - Crtc
  - Myc
  - Dsor1
  - Mtk
  - Thor
  - Polr2A
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - svr
  - PolI
  - MKP-4
  - p38b
  - rl
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - RpS6
  - Polr2C
  - Polr2B
  - Polr2I
  - Polr2F
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PTEN
  - RPTOR
  - MYC
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EIF4EBP1
  - ERVW-4
  - POLI
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EIF4E
  - EIF4E2
  - EIF4E3
  - RPS6
  - tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
